Stop TB Partnership

Selection Criteria, Committee, and Ceremony


Selection Criteria

  1. The extent to which the nominee has made an exceptional contribution to improving the TB response for people with TB, communities affected by TB or service delivery, especially through providing health services, support, nursing or engagement in research, innovation, policy and partnership development, or advocacy.
  2. The extent to which the nominee has shown outstanding understanding or conducted advocacy on behalf of people affected by TB.
  3. The extent to which the Kochon Prize will contribute to furthering the nominee's work in TB nursing.

Selection Committee is composed of:

Mr Timur Abdullaev
Stop TB Partnership Board Member

Dr Kenneth Castro
Clinical Assistant Professor, Emory University School of Public Health
United States of America

Dr Paula Fujiwara
Scientific Director, International Union Against Tuberculosis and Lung Disease

Mr. Woo Young Soo
Executive Director, Kochon Foundation
Republic of Korea

Dr Mel Spigelman
President and CEO, Global Alliance for TB Drug Development
Co-Chair, Working Group on New TB Drugs
United States of America

Award Announcement and Ceremony

Details of the 2020 Kochon Prize will be announced at a later date.